COVID-19 Vaccine Uptake App for Telemedicine

Phase-Based Progress Estimates
University of Nebraska Medical Center, Omaha, NE
Telemedicine+4 More
COVID-19 Vaccine Uptake App - Behavioral
All Sexes
What conditions do you have?

Study Summary

This study will determine the effectiveness of a vaccine communication mobile health app on parental decisions to vaccinate their children against coronavirus disease 2019 (COVID-19). The hypothesis is that unvaccinated children of caregivers assigned to the Vaccine Uptake app will be more likely to achieve COVID-19 vaccine series completion than those children whose caregivers are assigned to the General Health app.

Eligible Conditions

  • Telemedicine
  • Covid19, Vaccines
  • ALL, Pediatric
  • Vaccine Hesitancy

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Week 24

16 weeks
Change in enrolled parent/caregiver domain scores from baseline to immediately post-intervention on the modified WHO SAGE Vaccine Hesitancy Scale adapted for the COVID-19 Vaccine
Week 24
Proportion of children who complete COVID-19 vaccination, as verified in state, clinic, or participant-held records
Proportion of children who receive ≥1 dose of the COVID-19 vaccination series, as verified in state, clinic, or participant-held records

Trial Safety

Trial Design

2 Treatment Groups

General Health App
1 of 2
Vaccine Uptake App
1 of 2
Active Control
Experimental Treatment

892 Total Participants · 2 Treatment Groups

Primary Treatment: COVID-19 Vaccine Uptake App · No Placebo Group · N/A

Vaccine Uptake App
Experimental Group · 1 Intervention: COVID-19 Vaccine Uptake App · Intervention Types: Behavioral
General Health App
ActiveComparator Group · 1 Intervention: General Health App · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: week 24
Closest Location: University of Nebraska Medical Center · Omaha, NE
Photo of university of nebraska medical center  1Photo of university of nebraska medical center  2Photo of university of nebraska medical center  3
2010First Recorded Clinical Trial
2 TrialsResearching Telemedicine
568 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a minor as defined by the state of residency.
You are a parent or caregiver.
You are eligible to receive the COVID-19 vaccine.
You have access to a mobile device that can store and run the study app for 24 weeks
You are a parent/caregiver with primary medical decision-making and legal authority to consent to vaccination decisions for at least one child who meets the child inclusion criteria.
You are 6 months to less than the age of majority, as defined by the child's state of residence.
You have not received any doses of COVID-19 vaccine based on parent/caregiver report.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.